Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metafrax Chemicals is a leading Russian industrial chemical producer and one of the largest manufacturers of methanol and its derivatives in Europe. The company's core portfolio includes formalin, pentaerythritol, urotropine, and urea-formaldehyde resins, which serve critical roles in the construction, woodworking, and pharmaceutical sectors. Notably, Metafrax produces medical-grade urotropine, used as an antiseptic for urinary tract infections, and paraformaldehyde for laboratory use. Headquartered in Gubakha, the company was historically a public entity but was nationalized by the Russian government in late 2023. It remains a vital supplier of chemical building blocks for both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metafrax Chemicals.